Matinas BioPharma Holdings, Inc.
MTNB
$1.65
$0.042.36%
AMEX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -96.42% | |||
| Gross Profit | -- | 96.42% | |||
| SG&A Expenses | -1.29% | 11.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.60% | -51.81% | |||
| Operating Income | 5.60% | 51.81% | |||
| Income Before Tax | -216.73% | 80.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -216.73% | 80.36% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -216.73% | 80.36% | |||
| EBIT | 5.60% | 51.81% | |||
| EBITDA | 5.35% | 51.18% | |||
| EPS Basic | -216.77% | 80.36% | |||
| Normalized Basic EPS | 2.59% | 52.21% | |||
| EPS Diluted | -216.77% | 80.36% | |||
| Normalized Diluted EPS | 2.59% | 52.21% | |||
| Average Basic Shares Outstanding | 0.00% | -0.03% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||